RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

Benzinga · 2d ago
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.